EGFR and glioblastoma: The molecular diagnosis of IDH-wildtype GBM can be established based on the following three molecular parameters: the combined gain of chromosome 7 and loss of chromosome 10 (7+/10−), epidermal growth factor receptor (EGFR) amplification, and telomerase reverse transcriptase (TERT) promoter mutation [2].